Robert C. Moscato, Jr
Overview
Robert C. Moscato, Jr received $436K in total compensation, including $191K in salary, at Marina Biotech in 2018. Robert Moscato also received an average of $148K at Avalo Therapeutics between 2017 and 2018.
Source: SEC filings on November 19, 2019, June 19, 2019, and April 5, 2018.
Related executives
We found 24 more executives who work or worked at Marina Biotech and Avalo Therapeutics.
Garry Neil
Avalo Therapeutics
Chief Executive Officer
Stephen Smolinski
Avalo Therapeutics
Former Chief Commercial Officer
Michael Cola
Avalo Therapeutics
Chief Executive Officer
Christopher Sullivan
Avalo Therapeutics
Chief Financial Officer
Schond Greenway
Avalo Therapeutics
Chief Financial Officer
H Wilkins
Avalo Therapeutics
Chief Medical Officer
Simon Pedder
Avalo Therapeutics
Chairman
Pericles Calias
Avalo Therapeutics